Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Frequent premature atrial contractions are associated with atrial fibrillation, brain ischaemia, and mortality: a systematic review and meta-analysis.

Himmelreich JCL, Lucassen WAM, Heugen M, Bossuyt PMM, Tan HL, Harskamp RE, van Etten-Jamaludin FS, van Weert HCPM.

Europace. 2018 Dec 1. doi: 10.1093/europace/euy276. [Epub ahead of print]

PMID:
30508087
2.

Rethinking revascularization in patients with stable angina.

Harskamp RE, Park DW.

Expert Rev Cardiovasc Ther. 2018 Mar;16(3):159-161. doi: 10.1080/14779072.2018.1429915. Epub 2018 Jan 21.

PMID:
29338462
3.

Palpitations: when you hear hoof beats don't forget to think zebras.

Harskamp RE, Thole OB, Moggré I.

Practitioner. 2017 Apr;261(1803):23-5.

PMID:
29020730
4.

Nonsteroidal Anti-Inflammatory Drugs and Clinical Outcomes in Patients Undergoing Coronary Artery Bypass Surgery.

de Souza Brito F, Mehta RH, Lopes RD, Harskamp RE, Lucas BD Jr, Schulte PJ, Tardif JC, Alexander JH.

Am J Med. 2017 Apr;130(4):462-468. doi: 10.1016/j.amjmed.2016.10.023. Epub 2016 Nov 23.

PMID:
27888052
5.

Response to Letters Regarding Article, "Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial".

Harskamp RE, Alexander JH, Ferguson TB Jr, Hager R, Mack MJ, Englum B, Wojdyla D, Schulte PJ, Kouchoukos NT, de Winter RJ, Gibson CM, Peterson ED, Harrington RA, Smith PK, Lopes RD.

Circulation. 2016 May 24;133(21):e665. doi: 10.1161/CIRCULATIONAHA.116.022510. No abstract available.

PMID:
27217439
6.

Use of thienopyridine prior to presentation with non-ST-segment elevation acute coronary syndrome and association with safety and efficacy of vorapaxar: insights from the TRACER trial.

Harskamp RE, Clare RM, Ambrosio G, Held C, Lokhnygina Y, Moliterno DJ, White HD, Aylward PE, Armstrong PW, Mahaffey KW, Harrington RA, Van de Werf F, Wallentin L, Strony J, Tricoci P.

Eur Heart J Acute Cardiovasc Care. 2017 Mar;6(2):155-163. doi: 10.1177/2048872616633880. Epub 2016 Sep 20.

PMID:
26895973
7.

The role of diabetes mellitus in the composition of coronary thrombi in patients presenting with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Sebben JC, Pinto Ribeiro DR, Lopes RD, de Winter R, Harskamp R, Cambruzzi E, Schmidt MM, Martinelli ES, Gottschall CA, Quadros AS.

Am Heart J. 2016 Feb;172:26-33. doi: 10.1016/j.ahj.2015.10.003. Epub 2015 Oct 9.

PMID:
26856212
8.

Hybrid coronary revascularization versus coronary artery bypass surgery with bilateral or single internal mammary artery grafts.

Rosenblum JM, Harskamp RE, Hoedemaker N, Walker P, Liberman HA, de Winter RJ, Vassiliades TA, Puskas JD, Halkos ME.

J Thorac Cardiovasc Surg. 2016 Apr;151(4):1081-9. doi: 10.1016/j.jtcvs.2015.10.061. Epub 2015 Oct 26.

9.

Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial.

Harskamp RE, Alexander JH, Ferguson TB Jr, Hager R, Mack MJ, Englum B, Wojdyla D, Schulte PJ, Kouchoukos NT, de Winter RJ, Gibson CM, Peterson ED, Harrington RA, Smith PK, Lopes RD.

Circulation. 2016 Jan 12;133(2):131-8. doi: 10.1161/CIRCULATIONAHA.115.015549. Epub 2015 Dec 8.

10.

Procedural and clinical outcomes after use of the glycoprotein IIb/IIIa inhibitor abciximab for saphenous vein graft interventions.

Harskamp RE, Hoedemaker N, Newby LK, Woudstra P, Grundeken MJ, Beijk MA, Piek JJ, Tijssen JG, Mehta RH, de Winter RJ.

Cardiovasc Revasc Med. 2016 Jan-Feb;17(1):19-23. doi: 10.1016/j.carrev.2015.09.005. Epub 2015 Oct 31.

PMID:
26626961
11.

Current state and future direction of hybrid coronary revascularization.

Harskamp RE.

Curr Opin Cardiol. 2015 Nov;30(6):643-9. doi: 10.1097/HCO.0000000000000223. Review.

PMID:
26447502
12.

The Preservation and Handling of Vein Grafts in Current Surgical Practice: Findings of a Survey Among Cardiovascular Surgeons of Top-Ranked US Hospitals.

Williams JB, Harskamp RE, Bose S, Lawson JH, Alexander JH, Smith PK, Lopes RD.

JAMA Surg. 2015 Jul;150(7):681-3. doi: 10.1001/jamasurg.2015.0404. No abstract available.

PMID:
25970819
13.

Comparative Effectiveness of Hybrid Coronary Revascularization vs Coronary Artery Bypass Grafting.

Harskamp RE, Vassiliades TA, Mehta RH, de Winter RJ, Lopes RD, Xian Y, Peterson ED, Puskas JD, Halkos ME.

J Am Coll Surg. 2015 Aug;221(2):326-34.e1. doi: 10.1016/j.jamcollsurg.2015.03.012. Epub 2015 Mar 20.

PMID:
25899734
14.

A nationwide survey on perception, experience, and expectations of hybrid coronary revascularization among top-ranked US hospitals.

Harskamp RE, Halkos ME, Xian Y, Szerlip MA, Poston RS, Mick SL, Lopes RD, Tijssen JG, de Winter RJ, Peterson ED.

Am Heart J. 2015 Apr;169(4):557-63.e6. doi: 10.1016/j.ahj.2015.01.003. Epub 2015 Jan 7.

PMID:
25819863
15.

Stenting versus surgery for significant left main disease.

Harskamp RE, Park DW.

Curr Cardiol Rep. 2015;17(4):18. doi: 10.1007/s11886-015-0574-z. Review.

PMID:
25702314
16.

Reply: To PMID 24360877.

Harskamp RE, Schulte PJ, Alexander JH, Lopes RD.

Ann Thorac Surg. 2014 Nov;98(5):1890. doi: 10.1016/j.athoracsur.2014.08.076. Epub 2014 Oct 30. No abstract available.

PMID:
25441825
17.

Soluble urokinase-type plasminogen activator receptor: a useful biomarker for coronary artery disease and clinical outcomes?

Harskamp RE, Roe MT.

J Am Heart Assoc. 2014 Oct 23;3(5):e001431. doi: 10.1161/JAHA.114.001431. No abstract available.

18.

Clinical outcomes of hybrid coronary revascularization versus coronary artery bypass surgery in patients with diabetes mellitus.

Harskamp RE, Walker PF, Alexander JH, Xian Y, Liberman HA, de Winter RJ, Vassiliades TA, Peterson ED, Puskas JD, Halkos ME.

Am Heart J. 2014 Oct;168(4):471-8. doi: 10.1016/j.ahj.2014.06.027. Epub 2014 Jul 11.

PMID:
25262256
19.

Cardiac troponin release following hybrid coronary revascularization versus off-pump coronary artery bypass surgery.

Harskamp RE, Abdelsalam M, Lopes RD, Boga G, Hirji S, Krishnan M, Kiljanek L, Mumtaz M, Tijssen JG, McCarty C, de Winter RJ, Bachinsky WB.

Interact Cardiovasc Thorac Surg. 2014 Dec;19(6):1008-12. doi: 10.1093/icvts/ivu297. Epub 2014 Sep 12.

PMID:
25217621
20.

Vein graft preservation solutions, patency, and outcomes after coronary artery bypass graft surgery: follow-up from the PREVENT IV randomized clinical trial.

Harskamp RE, Alexander JH, Schulte PJ, Brophy CM, Mack MJ, Peterson ED, Williams JB, Gibson CM, Califf RM, Kouchoukos NT, Harrington RA, Ferguson TB Jr, Lopes RD.

JAMA Surg. 2014 Aug;149(8):798-805. doi: 10.1001/jamasurg.2014.87. Erratum in: JAMA Surg. 2014 Sep;149(9):961.

21.

Practice patterns and clinical outcomes after hybrid coronary revascularization in the United States: an analysis from the society of thoracic surgeons adult cardiac database.

Harskamp RE, Brennan JM, Xian Y, Halkos ME, Puskas JD, Thourani VH, Gammie JS, Taylor BS, de Winter RJ, Kim S, O'Brien S, Peterson ED, Gaca JG.

Circulation. 2014 Sep 9;130(11):872-9. doi: 10.1161/CIRCULATIONAHA.114.009479. Epub 2014 Jul 23.

PMID:
25055814
22.

Central venous pressure after coronary artery bypass surgery: does it predict postoperative mortality or renal failure?

Williams JB, Peterson ED, Wojdyla D, Harskamp R, Southerland KW, Ferguson TB, Smith PK, Milano CA, Lopes RD.

J Crit Care. 2014 Dec;29(6):1006-10. doi: 10.1016/j.jcrc.2014.05.027. Epub 2014 Jun 9.

23.

Comparison of hybrid coronary revascularization versus coronary artery bypass grafting in patients≄65 years with multivessel coronary artery disease.

Harskamp RE, Puskas JD, Tijssen JG, Walker PF, Liberman HA, Lopes RD, Vassiliades TA, Peterson ED, Halkos ME.

Am J Cardiol. 2014 Jul 15;114(2):224-9. doi: 10.1016/j.amjcard.2014.04.028. Epub 2014 May 2.

PMID:
24878119
24.

Meta-analysis of minimally invasive coronary artery bypass versus drug-eluting stents for isolated left anterior descending coronary artery disease.

Harskamp RE, Williams JB, Halkos ME, Lopes RD, Tijssen JG, Ferguson TB Jr, de Winter RJ.

J Thorac Cardiovasc Surg. 2014 Nov;148(5):1837-42. doi: 10.1016/j.jtcvs.2014.03.028. Epub 2014 Mar 20. Review.

25.

ACP Journal Club. Review: CABG reduces long-term mortality and morbidity more than PCI in multivessel coronary disease.

Harskamp RE, Newby LK.

Ann Intern Med. 2014 Apr 15;160(8):JC9. doi: 10.7326/0003-4819-160-8-201404150-02009. No abstract available.

PMID:
24733226
26.

We need to do better for patients with non-ST-segment elevation acute coronary syndrome who are managed without revascularization.

Ohman EM, Harskamp RE.

J Am Coll Cardiol. 2014 Jun 3;63(21):2258-60. doi: 10.1016/j.jacc.2014.03.009. Epub 2014 Apr 2. No abstract available.

27.

Clinical outcomes after hybrid coronary revascularization versus coronary artery bypass surgery: a meta-analysis of 1,190 patients.

Harskamp RE, Bagai A, Halkos ME, Rao SV, Bachinsky WB, Patel MR, de Winter RJ, Peterson ED, Alexander JH, Lopes RD.

Am Heart J. 2014 Apr;167(4):585-92. doi: 10.1016/j.ahj.2014.01.006. Epub 2014 Jan 29. Review.

PMID:
24655709
28.

Hospital patterns of medical management strategy use for patients with non-ST-elevation myocardial infarction and 3-vessel or left main coronary artery disease.

Harskamp RE, Wang TY, Bhatt DL, Wiviott SD, Amsterdam EA, Li S, Thomas L, de Winter RJ, Roe MT.

Am Heart J. 2014 Mar;167(3):355-362.e3. doi: 10.1016/j.ahj.2013.12.004. Epub 2013 Dec 19.

PMID:
24576520
29.

Status quo of hybrid coronary revascularization for multi-vessel coronary artery disease.

Harskamp RE, Zheng Z, Alexander JH, Williams JB, Xian Y, Halkos ME, Brennan JM, de Winter RJ, Smith PK, Lopes RD.

Ann Thorac Surg. 2013 Dec;96(6):2268-77. Review.

30.

Impact of extracardiac vascular disease on vein graft failure and outcomes after coronary artery bypass surgery.

Harskamp RE, Alexander JH, Schulte PJ, Jones WS, Williams JB, Mack MJ, Peterson ED, Gibson CM, Califf RM, Kouchoukos NT, Ferguson TB, de Winter RJ, Lopes RD.

Ann Thorac Surg. 2014 Mar;97(3):824-30. doi: 10.1016/j.athoracsur.2013.09.099. Epub 2013 Dec 21.

31.

Standardizing definitions for hybrid coronary revascularization.

Harskamp RE, Bonatti JO, Zhao DX, Puskas JD, de Winter RJ, Alexander JH, Halkos ME.

J Thorac Cardiovasc Surg. 2014 Feb;147(2):556-60. doi: 10.1016/j.jtcvs.2013.10.019. Epub 2013 Nov 23. No abstract available.

32.

Optimal choice of coronary revascularization and stent type in diabetic patients with coronary artery disease.

Harskamp RE, Park DW.

Cardiol Ther. 2013 Jun;2(1):69-84. doi: 10.1007/s40119-013-0014-3. Epub 2013 Mar 26.

33.

Saphenous vein graft failure and clinical outcomes: toward a surrogate end point in patients following coronary artery bypass surgery?

Harskamp RE, Williams JB, Hill RC, de Winter RJ, Alexander JH, Lopes RD.

Am Heart J. 2013 May;165(5):639-43. doi: 10.1016/j.ahj.2013.01.019. Epub 2013 Mar 7.

34.

Percutaneous coronary intervention in diabetic patients: should choice of stents be influenced?

Harskamp RE, Park DW.

Expert Rev Cardiovasc Ther. 2013 May;11(5):541-53. doi: 10.1586/erc.13.38. Review.

PMID:
23621137
35.

Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions.

Harskamp RE, Lopes RD, Baisden CE, de Winter RJ, Alexander JH.

Ann Surg. 2013 May;257(5):824-33. doi: 10.1097/SLA.0b013e318288c38d. Review.

PMID:
23574989
36.

Prehospitalization antiplatelet therapy and outcomes after saphenous vein graft intervention.

Harskamp RE, Beijk MA, Damman P, Tijssen JG, Lopes RD, de Winter RJ.

Am J Cardiol. 2013 Jan 15;111(2):153-8. doi: 10.1016/j.amjcard.2012.09.010. Epub 2012 Oct 24.

PMID:
23102882
37.

Multiple biomarkers for the prediction of short and long-term mortality after ST-segment elevation myocardial infarction: the Amsterdam Groningen collaboration.

Damman P, Kampinga MA, van der Horst IC, Woudstra P, Grundeken MJ, Kuijt WJ, Harskamp RE, Nijsten MW, Zijlstra F, Tijssen JG, de Smet BJ, de Winter RJ.

J Thromb Thrombolysis. 2013 Jul;36(1):42-6. doi: 10.1007/s11239-012-0809-4.

PMID:
23054461
38.

Short- and long-term prognostic value of the TIMI risk score after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.

Damman P, Woudstra P, Kuijt WJ, Kikkert WJ, van de Hoef TP, Grundeken MJ, Harskamp RE, Henriques JP, Piek JJ, Tijssen JG, de Winter RJ.

J Interv Cardiol. 2013 Feb;26(1):8-13. doi: 10.1111/j.1540-8183.2012.00763.x. Epub 2012 Sep 12.

PMID:
22971136
39.

Clinical outcome after surgical or percutaneous revascularization in coronary bypass graft failure.

Harskamp RE, Beijk MA, Damman P, Kuijt WJ, Woudstra P, Grundeken MJ, Kloek JJ, Tijssen JG, de Mol BA, de Winter RJ.

J Cardiovasc Med (Hagerstown). 2013 Jun;14(6):438-45. doi: 10.2459/JCM.0b013e328356a4fc.

PMID:
22828774
40.

Six-month clinical outcomes of the Tryton Side Branch Stent for the treatment of bifurcation lesions.

Grundeken MJ, Smits M, Harskamp RE, Damman P, Woudstra P, Hoorweg AJ, Baan J Jr, Arkenbout EK, Piek JJ, Vis MM, Henriques JP, Koch KT, Tijssen JG, de Winter RJ, Wykrzykowska JJ.

Neth Heart J. 2012 Nov;20(11):439-46. doi: 10.1007/s12471-012-0302-x.

41.

Clinical outcomes after bare-metal stenting in diabetic patients with lesions carrying a low risk of restenosis.

Woudstra P, Damman P, Beijk MA, Grundeken MJ, Harskamp RE, Koch KT, Henriques JP, Baan J Jr, Vis MM, Piek JJ, Tijssen JG, de Winter RJ.

Catheter Cardiovasc Interv. 2013 Jan 1;81(1):26-33. doi: 10.1002/ccd.24444. Epub 2012 Nov 8.

PMID:
22511590
42.

Percutaneous coronary intervention for acute coronary syndrome due to graft failure: use of bare-metal and drug-eluting stents and subsequent long-term clinical outcome.

Harskamp RE, Kuijt WJ, Damman P, Beijk MA, Grundeken MJ, Woudstra P, Tijssen JG, de Winter RJ.

Catheter Cardiovasc Interv. 2014 Feb;83(2):203-9. doi: 10.1002/ccd.24441. Epub 2013 Oct 21.

PMID:
22508617
43.

Gender difference in the prognostic value of estimated glomerular filtration rate at admission in ST-segment elevation myocardial infarction: a prospective cohort study.

Damman P, Kikkert WJ, Woudstra P, Kuijt WJ, Grundeken MJ, Harskamp RE, Baan J, Vis MM, Henriques JP, Piek JJ, van Straalen JP, Fischer JC, Tijssen JG, de Winter RJ.

BMJ Open. 2012 Mar 2;2(2):e000322. doi: 10.1136/bmjopen-2011-000322. Print 2012.

44.
45.

Acute respiratory tract infections: a potential trigger for the acute coronary syndrome.

Harskamp RE, van Ginkel MW.

Ann Med. 2008;40(2):121-8. doi: 10.1080/07853890701753672. Review.

PMID:
18293142
46.

Postoperative internal thoracic artery spasm after coronary artery bypass grafting.

Harskamp RE, McNeil JD, van Ginkel MW, Bastos RB, Baisden CE, Calhoon JH.

Ann Thorac Surg. 2008 Feb;85(2):647-9. doi: 10.1016/j.athoracsur.2007.08.015.

PMID:
18222288
47.

Interleukin-18 stimulates fibronectin expression in primary human cardiac fibroblasts via PI3K-Akt-dependent NF-kappaB activation.

Reddy VS, Harskamp RE, van Ginkel MW, Calhoon J, Baisden CE, Kim IS, Valente AJ, Chandrasekar B.

J Cell Physiol. 2008 Jun;215(3):697-707.

PMID:
18064631
48.

Preeclampsia: at risk for remote cardiovascular disease.

Harskamp RE, Zeeman GG.

Am J Med Sci. 2007 Oct;334(4):291-5. Review.

PMID:
18030186

Supplemental Content

Loading ...
Support Center